Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research report issued on Tuesday. The firm set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright reiterated a “buy” rating and set a $7.00 price objective on shares of Aethlon Medical in a research note on Friday, November 15th.

Aethlon Medical Stock Down 2.6 %

Shares of AEMD opened at $0.37 on Tuesday. The firm has a market cap of $5.16 million, a price-to-earnings ratio of -0.13 and a beta of 1.79. The business’s 50 day moving average is $0.39 and its two-hundred day moving average is $0.42. Aethlon Medical has a 52-week low of $0.24 and a 52-week high of $2.35.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.